Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in active nonradiographic axial spondyloarthritis
RBR-2pk58pPhase 3Recruiting
- Sponsor
- CPClin
- Start
- Jun 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ustekinumab in non-radiographic axial spondyloarthritis (nr-axSpA) (3 arms), sponsored by CPClin. Started Jun 2015; status: recruiting.
02
Drugs
ustekinumab
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on RBR-2pk58p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2pk58p.